North America Schizophrenia Drugs Market Size & Outlook
Related Markets
North America schizophrenia drugs market highlights
- The North America schizophrenia drugs market generated a revenue of USD 3,165.0 million in 2024.
- The market is expected to grow at a CAGR of 4.7% from 2025 to 2030.
- In terms of segment, second generation antipsychotics was the largest revenue generating class in 2024.
- Third Generation Antipsychotics is the most lucrative class segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 3,165.0 million |
| Market revenue in 2030 | USD 4,102.3 million |
| Growth rate | 4.7% (CAGR from 2025 to 2030) |
| Largest segment | Second generation antipsychotics |
| Fastest growing segment | Third Generation Antipsychotics |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Second Generation Antipsychotics, Third Generation Antipsychotics |
| Key market players worldwide | Johnson & Johnson, Bristol-Myers Squibb Co, AstraZeneca PLC, Sumitomo Dainippon Pharma Oncology, Eli Lilly and Co, Alkermes PLC, Allergan, Pfizer Inc, H. Lundbeck AS Class A |
Other key industry trends
- In terms of revenue, North America region accounted for 38.6% of the global schizophrenia drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,105.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Schizophrenia Drugs Market Scope
Schizophrenia Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alkermes PLC | View profile | 2100 | 1 Burlington Road, Connaught House, Dublin, Ireland, D04 C5Y6 | https://www.alkermes.com |
| Sumitomo Dainippon Pharma Oncology | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | https://www.sdponcology.com/ |
| H. Lundbeck AS Class A | View profile | 5700 | Ottiliavej 9, Valby, Denmark, 2500 | https://www.lundbeck.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Allergan | View profile | 10001+ | Madison, Wisconsin, United States, North America | http://www.allergan.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
North America schizophrenia drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to schizophrenia drugs market will help companies and investors design strategic landscapes.
Second generation antipsychotics was the largest segment with a revenue share of 75.41% in 2024. Horizon Databook has segmented the North America schizophrenia drugs market based on second generation antipsychotics, third generation antipsychotics covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America schizophrenia drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America schizophrenia drugs market databook
-
Our clientele includes a mix of schizophrenia drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America schizophrenia drugs market , including forecasts for subscribers. This continent databook contains high-level insights into North America schizophrenia drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America schizophrenia drugs market size, by country, 2018-2030 (US$M)
North America Schizophrenia Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
